pyrazolanthrone has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, CZ; Shyu, KG; Wang, BW; Yu, YJ | 1 |
| Cao, Q; Chen, GL; Fang, WH; Jiang, XR; Li, HH; Li, M; Li, Y; Liu, X; Ping, GF; Wang, LH; Wang, S; Wu, CF; Yang, JY | 1 |
| Bian, XW; Chen, GL; Cui, YH; Duan, JJ; Gu, A; Li, TT; Qian, C; Shi, Y; Xin, YH; Xu, C; Yang, XJ; Yu, SC; Zhang, X | 1 |
| Naruishi, K; Nishimura, F; Omori, K; Takashiba, S; Yamada-Naruishi, H; Yamaguchi, M | 1 |
| Chen, LN; Fan, CM; Jia, JF; Wang, CH; Wang, YH; Zhu, P | 1 |
| Boyle, JO; Dannenberg, AJ; Du, B; Gross, ND; Kekatpure, VD; Lantowski, A; Subbaramaiah, K; Thaler, HT; Weksler, BB | 1 |
6 other study(ies) available for pyrazolanthrone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Hyperbaric oxygen activates visfatin expression and angiogenesis via angiotensin II and JNK pathway in hypoxic human coronary artery endothelial cells.
Topics: Angiotensin II; Anthracenes; Cell Movement; Cells, Cultured; Coronary Vessels; Cytokines; Endothelial Cells; Glucose; Humans; Hyperbaric Oxygenation; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; JNK Mitogen-Activated Protein Kinases; Losartan; Neovascularization, Pathologic; Nicotinamide Phosphoribosyltransferase; Oxygen; Promoter Regions, Genetic; RNA, Small Interfering; Signal Transduction | 2020 |
SL4, a chalcone-based compound, induces apoptosis in human cancer cells by activation of the ROS/MAPK signalling pathway.
Topics: Animals; Anthracenes; Apoptosis; bcl-X Protein; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Enzyme Activation; Female; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1; Imidazoles; Inhibitor of Apoptosis Proteins; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Pyridines; Reactive Oxygen Species; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2015 |
TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model.
Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Anthracenes; Cell Line, Tumor; Cell Movement; Chromones; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glioma; High-Throughput Screening Assays; Humans; Imidazoles; Macrophages; MAP Kinase Kinase 4; Morpholines; Neovascularization, Pathologic; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Signal Transduction; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays; Zebrafish | 2013 |
C-jun N-terminal kinase (JNK) inhibitor, SP600125, blocks interleukin (IL)-6-induced vascular endothelial growth factor (VEGF) production: cyclosporine A partially mimics this inhibitory effect.
Topics: Anthracenes; Cells, Cultured; Cyclosporine; Enzyme Inhibitors; Fibroblasts; Gingiva; Humans; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Phosphorylation; Vascular Endothelial Growth Factor A | 2003 |
[CD147 stimulates the angiogenesis in rheumatoid synovium via the activation of vascular endothelial growth factor].
Topics: Adult; Aged; Anthracenes; Arthritis, Rheumatoid; Basigin; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Chromones; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Female; Flavonoids; Humans; Lymphocytes; Macrophages; Male; Middle Aged; Morpholines; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Osteoarthritis; Phosphoinositide-3 Kinase Inhibitors; Polymerase Chain Reaction; Signal Transduction; Synovial Membrane; Vascular Endothelial Growth Factor A; Young Adult | 2007 |
Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma.
Topics: Animals; Anthracenes; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Collagen; Drug Combinations; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Head and Neck Neoplasms; Humans; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Laminin; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Proteoglycans; RNA Interference | 2007 |